OQROGet OQRO Pro
Insider trade

Cencora (COR)Executive Vice President sold ~$384K

Silvana Battaglia, Executive Vice President at Cencora, sold ~$384K of Cencora shares.

~$384K
Approx. value · 1,678 sh @ $228.72
20K
Holds after · shares reported
Traded
Dec 20, 2024
Filed
Dec 23, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 22, 2024InsiderChair sold ~$5.07M of COR shares in the open market
  2. Nov 14, 2024FDARecall: Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoin…
  3. Nov 14, 2024FDARecall: Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobi…
  4. Nov 14, 2024FDARecall: Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint…
  5. Nov 19, 2024InsiderChair sold ~$5.21M of COR shares in the open market
  6. Nov 25, 2024InsiderChair sold ~$12.2M of COR shares in the open market
  7. Dec 3, 2024InsiderOfficer sold ~$455K of COR shares in the open market
  8. Dec 6, 2024FDARecall: Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint…
  9. Dec 6, 2024FDARecall: Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint L…
  10. Dec 6, 2024FDARecall: Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint L…
  11. Dec 6, 2024FDARecall: Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoi…
  12. Dec 13, 2024FDARecall: Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Pack…
  13. Dec 17, 2024FDARecall: glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Ca…
  14. Dec 20, 2024 · this disclosureInsiderOfficer sold ~$384K of COR shares in the open market

What came next

  1. Jan 7, 2025FDARecall: Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Pack…
  2. Feb 6, 2025Insider · 1 personInsiders: 2 sales (~$314.5M)
  3. Feb 21, 2025InsiderOfficer sold ~$1.21M of COR shares in the open market
  4. Feb 27, 2025Insider · 1 personInsiders: 2 sales (~$3.7M)
  5. Mar 3, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  6. Mar 10, 2025InsiderOfficer sold ~$520K of COR shares in the open market
  7. Mar 18, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  8. Mar 24, 2025FDARecall: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: Amer…
  9. Mar 24, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
  10. Mar 25, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
  11. Mar 27, 2025CongressDisclosed sale of COR — reported range $15,001 - $50,000
  12. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nela…
  13. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelam…
  14. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Silvana Battaglia, Executive Vice President

The full history of Silvana Battaglia, Executive Vice President is on the profile page.

How this filing works

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data